TABLE 2.
Characteristics | Low-risk subtype n = 412 | High-risk subtype n = 72 | p Value |
---|---|---|---|
CT characteristics | <0.001 | ||
GGO components | 323 (78.4) | 36 (50.0) | |
Pure solid | 89 (21.6) | 36 (50.0) | |
EGFR gene mutation | <0.001 a | ||
Negative | 92 (22.3) | 34 (47.2) | |
Positive | 198 (48.1) | 20 (27.8) | |
Unknown | 122 (29.6) | 18 (25.0) | |
ALK rearrangement | 0.017 a | ||
Negative | 273 (66.3) | 47 (65.3) | |
Positive | 6 (1.5) | 5 (6.9) | |
Unknown | 133 (32.3) | 72 (27.8) |
EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; CT, computed tomography; GGO, ground-glass opacity.
The p value was calculated excluded the patients with unknown EGFR and ALK status.